SAN DIEGO — Patients with Philadelphia chromosome-negative accelerated- or blast-phase myeloproliferative neoplasms who received allogeneic hematopoietic stem cells had a longer median OS than those ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback